Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  CVS Health    CVS

 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Discover our TOP LISTS, the world's most profitable stocks to hold Get it NOW!
Quotes 5-day view   Delayed Quote. Delayed Nyse
06/19/2017 06/20/2017 06/21/2017 06/22/2017 06/23/2017 Date
78.1(c) 77.78(c) 78.16(c) 77.22(c) 77.41(c) Last
5 949 670 5 729 069 4 777 375 5 369 655 15 833 813 Volume
+1.35% -0.41% +0.49% -1.20% +0.25% Change
More quotes
Financials ($)
Sales 2017 184 206 M
EBIT 2017 10 161 M
Net income 2017 5 384 M
Debt 2017 24 614 M
Yield 2017 2,54%
Sales 2018 194 050 M
EBIT 2018 10 594 M
Net income 2018 5 805 M
Debt 2018 24 916 M
Yield 2018 2,85%
P/E ratio 2017 15,02
P/E ratio 2018 13,29
EV / Sales2017 0,56x
EV / Sales2018 0,53x
Capitalization 78 865 M
More Financials
Company
CVS Health Corp. engages in the provision of health care services.It operates trough the following segments: Pharmacy Services, Retail or Long Term Care, and Corporate.The Pharmacy Services segment offers pharmacy benefit management solutions.The Retail or Long Term Care segment includes selling of... 
Read more
Sector
Drug Retailers
Calendar
08/08Earnings Release
More about the company
Surperformance© ratings of CVS Health
Trading Rating : Investor Rating :
More Ratings
Latest news on CVS HEALTH
06/23 CVS HEALTH : appeals to the City Council in its effort to move into Laguna Drug ..
06/21 CVS HEALTH : Points of Light Recognizes CVS Health As One Of The 50 Most Communi..
06/21 CVS : Experts Discuss How Medicaid Innovations Reduce Costs and Increase Access ..
06/21 CVS HEALTH : Monroe County's tax battle with CVS not over
06/19 CVS HEALTH : Today's Research Reports on Stocks to Watch: CVS Health and Walgree..
06/16 CVS : By the Numbers: Real-World Impact of Rising Drug Costs
06/15 CVS HEALTH : Pharmacy Now Using Time Delay Safes in Ohio for Controlled Substanc..
06/14 CVS HEALTH : Medicaid as a Driver of Care Innovation
06/13 CVS HEALTH : Joins Drug Store News and Mack Elevation in Convening Health Innova..
06/13 CVS : Protecting Consumers in an Environment of Rising Drug Prices
More news
Sector news : Drug Retailers - NEC
06/22DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens to Settle -- WSJ
06/21DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens Reach Deal to Settle Lawsuit--Upd..
06/21 STADA ARZNEIMITTEL : Low acceptances leave Stada bid down to the wire
06/21DJWALGREENS BOOTS ALLIANCE : Theranos, Walgreens Reach Deal to Settle Lawsuit
06/20 U.S. Supreme Court again limits where companies can be sued
More sector news : Drug Retailers - NEC
4-Traders Strategies on CVS HEALTH 
2016The USD 93.2 area for a technical rebound
2015Back on its bullish trend
More Strategies
Latest Tweets
11:13aAdvisor Partners LLC Buys 4,660 Shares of CVS Health Corporation $CVS  
10:56aCVS Health Corporation $CVS Position Decreased by Jennison Associates LLC  
10:56aCVS Health Corporation $CVS Shares Sold by Tocqueville Asset Management L.P. .. 
06:12aCVS Health Corporation $CVS Expected to Post Earnings of $1.31 Per Share  
06/23The MnM Portfolio, June 2017 Supplement - How Amazon-Proof Is The Portfolio? .. 
More tweets
Qtime:132
News from SeekingAlpha
06/23 The MnM Portfolio, June 2017 Supplement - How Amazon-Proof Is The Portfolio?
06/23 AMAZON PURCHASES WHOLE FOODS : The Global Context
06/22 U.S Oil, The Permian And Global Outlook
06/21 Buying Dividend Growth Stocks Without Looking - More Than 2 Years Later
06/21 PREMARKET GAINERS AS OF 9 : 05 am
Advertisement
Chart CVS HEALTH
Duration : Period :
CVS Health Technical Analysis Chart | CVS | US1266501006 | 4-Traders
Full-screen chart
Technical analysis trends CVS HEALTH
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Average target price 87,1 $
Spread / Average Target 12%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Larry J. Merlo President, CEO & Non-Independent Director
David Wyatt Dorman Non-Executive Chairman
Jonathan C. Roberts Chief Operating Officer & Executive Vice President
David M. Denton Chief Financial Officer & Executive Vice President
Troyen A. Brennan Chief Medical Officer & Executive Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CVS HEALTH-1.90%78 865
WALGREENS BOOTS ALLIAN..-7.76%82 520
EXPRESS SCRIPTS HOLDIN..-5.19%39 152
MCKESSON CORPORATION18.88%35 305
CARDINAL HEALTH INC9.42%25 170
AMERISOURCEBERGEN CORP..23.25%20 923
More Results
4-traders.com :
About :
Stay Connected :
Partners :
Copyright © 2017 Surperformance. All rights reserved.